Literature DB >> 3643650

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

N C Pedersen, E W Ho, M L Brown, J K Yamamoto.   

Abstract

A highly T-lymphotropic virus was isolated from cats in a cattery in which all the animals were seronegative for feline leukemia virus. A number of cats in one pen had died and several had an immunodeficiency-like syndrome. Only 1 of 18 normal cats in the cattery showed serologic evidence of infection with this new virus, whereas 10 of 25 cats with signs of ill health were seropositive for the virus. Tentatively designated feline T-lymphotropic lentivirus, this new feline retrovirus appears to be antigenically distinct from human immunodeficiency virus. There is no evidence for cat-to-human transmission of the agent. Kittens experimentally infected by way of blood or plasma from naturally infected animals developed generalized lymphadenopathy several weeks later, became transiently febrile and leukopenic, and continued to show a generalized lymphadenopathy 5 months after infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3643650     DOI: 10.1126/science.3643650

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  321 in total

1.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.

Authors:  S Giannecchini; D Del Mauro; D Matteucci; M Bendinelli
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Detection of feline immunodeficiency provirus by seminested polymerase chain reaction.

Authors:  V Celer; H Kulhánková; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

Review 3.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes.

Authors:  K Nakagaki; K Nakagaki; K Takahashi; D Schols; E De Clercq; T Tabira
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

5.  Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

Authors:  A de Parseval; D L Lerner; P Borrow; B J Willett; J H Elder
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

7.  9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo.

Authors:  L Naesens; J Balzarini; I Rosenberg; A Holý; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

8.  Identification of a novel subtype of feline immunodeficiency virus in a population of naturally infected felines in the Brazilian Federal District.

Authors:  T G Marçola; C P C Gomes; P A Silva; G R Fernandes; G R Paludo; R W Pereira
Journal:  Virus Genes       Date:  2013-01-18       Impact factor: 2.332

9.  Neutralizing antibodies in cats infected with feline immunodeficiency virus.

Authors:  F Tozzini; D Matteucci; P Bandecchi; F Baldinotti; K Siebelink; A Osterhaus; M Bendinelli
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.